91Ó°ÊÓ

A group of veterinarians wants to test a new canine vaccine for Lyme disease. (Lyme disease is transmitted by the bite of an infected deer tick.) One hundred dogs are randomly selected to receive the vaccine (with their owners' permission) from an area that has a high incidence of Lyme disease. These dogs are examined by veterinarians for symptoms of Lyme disease once a month for a period of 12 months. During this 12 -month period, 10 of these 100 dogs are diagnosed with Lyme disease. During the same 12 -month period, \(18 \%\) of the unvaccinated dogs in the area are found to have contracted Lyme disease. a. Does this experiment have a control group? b. Is this a double-blind experiment? c. Identify any potential sources of bias in this experiment. d. Explain how this experiment could have been designed to reduce or eliminate the bias pointed out in part \(\mathrm{c}\).

Step by step solution

01

Identify the Control Group

A control group in an experiment is a group which does not receive the treatment or intervention and is used as a benchmark to measure the results of the test group. Here, the vaccinated dogs represent the test group. The control group in this experiment would be the unvaccinated dogs which provide a reference against which the health outcomes of the vaccinated dogs are compared.

02

Determine if this is a Double-Blind Experiment

A double-blind experiment is one in which neither the subjects (in this case, the dogs or their owners) nor the administrators (in this case, the veterinarians) know who has received the treatment (or vaccine). However, in this case, since the vaccines were administered with owners' permission and the veterinarians are aware of dogs receiving the vaccines, it's not a double-blind experiment.

03

Identify Potential Sources of Bias

Bias in an experiment can come from multiple sources. One potential source can be the selective sampling - as dogs were randomly selected but only from a single area. This does not provide a diverse sample representative of all dogs at different geographic locations. Another source of bias might come from diagnosing - If the veterinarians were aware which dogs were vaccinated, they might inadvertently diagnose Lyme disease differently in the vaccinated vs. unvaccinated dogs.

04

Reducing Bias in the Experiment

To eliminate or reduce the bias pointed out, the experiment could be redesigned in the following ways: \n1. Diverse Sampling: Dogs from several different areas should be included in both vaccinated and control groups to get a more representative sample. \n2. Double-Blind Experiment: A double-blind setup, where neither the owner nor the veterinarian it is known which dogs received the vaccine, would help remove bias in diagnosing.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Control Group

In experiments, a control group is essential for testing the effects of a new treatment by providing a benchmark to compare results. In the context of testing the new canine vaccine for Lyme disease, the control group comprises the unvaccinated dogs from the same geographic area. These dogs serve as a reference point to assess how effective the vaccine is. While the vaccinated dogs are the test group, comparing them with the unvaccinated ones helps determine if the vaccine significantly reduces Lyme disease incidence. A control group should ideally match the test group in every way except for the variable being tested, which in this case is the administration of the vaccine.

Having a well-defined control group helps ensure that any differences in outcomes can be attributed to the vaccine rather than other external factors or differences between the groups.

Double-Blind Experiment

A double-blind experiment is key in reducing bias by ensuring that neither the participants nor the administers know who receives the treatment. This type of setup prevents any subconscious influence on participants' reactions and helps avoid bias in how results are assessed. In this experiment with the canine vaccine for Lyme disease, the absence of a double-blind methodology is notable.

The owners' permission was required, and veterinarians knew which dogs were vaccinated. This awareness might influence the diagnosis or behavior of the veterinarians towards those dogs. Implementing a double-blind method would mean neither the veterinarians nor the owners knew which dogs received the vaccine, thereby providing more unbiased outcomes. This absence of foreknowledge is critical for maintaining objectivity in conducting experiments.

Bias in Experiments

Bias in experiments can skew results and lead to invalid conclusions. For the canine vaccine study, there were potential biases due to selective sampling and awareness of who received the vaccine. Selective sampling is evident as dogs were chosen from only one area, lacking representation of various environments where Lyme disease prevalence may vary. This can lead to results that aren't applicable to broader populations.

Additionally, bias might occur since veterinarians were aware which dogs were vaccinated. Their knowledge can inadvertently influence how symptoms are interpreted or diagnosed, potentially overestimating or underestimating the vaccine's effectiveness. Eliminating these biases is crucial for objective and accurate results.

Sampling Methods

Using appropriate sampling methods ensures that experimental samples represent the entire population accurately. In this Lyme disease vaccine experiment, dogs were randomly selected but only from one area, a method that hinders the generalization of results. It lacks diversity and representation across different geographic regions or environments, where factors like tick prevalence and dog exposure risks might differ.

To enhance the robustness of the study, diverse sampling is recommended, involving several locations to capture variations in potential Lyme disease exposure. This method aims to reflect the conditions across which the vaccine might be used, ensuring that results are applicable on a wider scale. Also, increasing the sample size can improve the validity and reliability of conclusions drawn from the experiment.